Coccygodynia

disease
On this page

Also known as coccydynia

Summary

Coccygodynia (MONDO:0022792) is a disease and 22 clinical trials. Top therapeutic interventions include dextrose and phenol. A subtype of vertebral column disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 22

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecoccygodynia
Mondo IDMONDO:0022792
ICD-11718979238
UMLSC0009193
MedGen507576
Anatomy (UBERON)UBERON:0001350
Is cancer (heuristic)no

Also known as: coccydynia

Disease family

This is a subtype of vertebral column disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorderskeletal system disordervertebral column disordercoccygodynia

Related subtypes (14): spondylocostal dysostosis, sacrum chordoma, epidural spinal canal neoplasm, Baastrup syndrome, lumbosacral lipoma, spinal stenosis, intervertebral disk degenerative disorder, vertebral joint disorder, sacrococcygeal teratoma, spinal cord injury, tuberculosis, spinal, vertebral disorder, lumbar disk disease, dropped head syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 22.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified20
PHASE32

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06023706PHASE3RECRUITINGStudy Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
NCT07060313PHASE3COMPLETEDTARGETING DUAL PATHWAYS IN REFRACTORY COCCYDYNIA
NCT06653179Not specifiedNOT_YET_RECRUITINGEfficacy of Interventional Methods Used in the Treatment of Coccydynia
NCT06858917Not specifiedRECRUITINGComparison of Impar Ganglion Block and Sacral Erector Spinae Plane Block in Patients with Coccygodynia
NCT06886568Not specifiedNOT_YET_RECRUITINGUltrasound Guided Ganglion Impar Block
NCT07021365Not specifiedNOT_YET_RECRUITINGComparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment
NCT07200765Not specifiedACTIVE_NOT_RECRUITINGEfficacy of Combining Caudal Epidural Steroid With Ganglion Impar Block in Chronic Coccydynia
NCT07426497Not specifiedRECRUITINGOsteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia
NCT07509593Not specifiedNOT_YET_RECRUITINGComparison of Single- and Double-Level Radiofrequency Ablation for Chronic Coccydynia
NCT07533617Not specifiedENROLLING_BY_INVITATIONChair-Integrated Foam Modifications in Coccydynia
NCT07552298Not specifiedRECRUITINGThe Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia
NCT07564167Not specifiedRECRUITINGUltrasound-Guided Dextrose Prolotherapy for Coccydynia: A Prospective Study
NCT02313324Not specifiedCOMPLETEDThe Effects of Extracorporeal Shock Wave Therapy in Patients With Coccydynia: A Randomized Controlled Trial
NCT02701192Not specifiedCOMPLETEDManagement of Coccydynia: A Prospective, Observational Study of Coccygectomy
NCT05683262Not specifiedCOMPLETEDThe Effect of USG-Guided Coccygeal Nerve Block on Sacrococcygeal And/or Intercoccygeal Joint Injection for Coccydynia
NCT06109077Not specifiedUNKNOWNComparative Effects of Levator Ani Release and Post Isometric Relaxation Among Patients With Coccydynia
NCT06848062Not specifiedCOMPLETEDValidation of the Paris (Functional Coccydynia Effect) Pain Questionnaire
NCT07076927Not specifiedCOMPLETEDSagittal Spinopelvic and Coccygeal Alignment in Sitting and Standing Positions in Coccydynia
NCT07089147Not specifiedCOMPLETEDPostpartum Coccydynia and the Paris Questionnaire
NCT07427212Not specifiedCOMPLETEDGanglion Impar vs Coccygeal Nerve Radiofrequency Ablation in Chronic Coccydynia
NCT07438678Not specifiedCOMPLETEDMaitland Mobilization and Lumbopelvic Coordination Exercises in Patients With Post Colonoscopy Coccydynia .
NCT07564362Not specifiedCOMPLETEDLandmark-Guided Dextrose Prolotherapy for Coccydynia: A Retrospective Study

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
DEXTROSE42
PHENOL41